free testosterone chemiluminescence immunoassay (EUROIMMUN ChLIA): FDA status

Approved Approved Jan 10, 2025. Indication: Free testosterone measurement for hypogonadism and impotence. Company: Revvity.

Regulatory history

All products in the FDA Tracker

Loading today's edition…